Publication number: 20190359547
Abstract: A compound of Formula I, wherein R1, R2, R3, R4, R5 and R6 are independently hydrogen, halogen, an unsubstituted alkyl, alkenyl, alkynyl, cydoalkyi, cydoalkylalkyi, aryl, phenyl, or naphthyl group, and a substituted alkyl, alkenyl, alkynyl, cydoalkyi, cydoalkylalkyi, aryl, phenyl, or naphthyl group having as a substituent a halogen, alkoxy, substituted phenoxy, unsubstituted phenoxy group or a heteroatom such as oxygen, sulfur, nitrogen, phosphorus and boron.
Type:
Application
Filed:
September 15, 2017
Publication date:
November 28, 2019
Applicant:
CURTIN UNIVERSITY OF TECHNOLOGY
Inventors:
Zora SINGH, Alan David PAYNE, Shamim Ahmed Kamal Uddin KHAN, Muftah Miload MUSA
Patent number: 10392385
Abstract: A compound of general formula A, useful as potential anticancer agents against human cancer cell lines and process for the preparation thereof. General formula A R1=3-F, 3,4,5-OMe, 4-OMe, H, 4-CF3, 4-Cl, 4-OH-3-OMe, 3,4-CH2—O—CH2, 3,5-F, 4-OH, 1-napthyl, 9-phenanthryl, 4-Me. R2=3,4,5-OMe, 3,4-Cl, 4-F, 3,5-F, 2,5-OMe, 4-Cl, 4-OH-3-OMe, 3-OH, 3,4,5-OH, 4-CF3, 4-OMe, 4-NH2.
Type:
Grant
Filed:
January 20, 2017
Date of Patent:
August 27, 2019
Assignee:
Council of Scientific & Industrial Research
Inventors:
Ahmed Kamal, Sathish Manda, Nagesh Narayana, Shankaraiah Nagula, Chetan Dushantrao Sabanis, Hari Krishna Namballa